Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
about
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaEmerging technologies in paediatric leukaemiaZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid MalignanciesDiagnosis and subclassification of acute lymphoblastic leukemiaRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineComprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaChildhood acute lymphoblastic leukemia: Integrating genomics into therapyPrognostification of ALL by CytogeneticsLNK/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitorsAberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic targetUse of single nucleotide polymorphism array technology to improve the identification of chromosomal lesions in leukemiaIntegrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumorsIntegration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray studyUp-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.Novel mechanism of tumor suppression by polarity gene discs large 1 (DLG1) revealed in a murine model of pediatric B-ALL.Integrative Analysis of MicroRNA-Mediated Gene Signatures and Pathways Modulating White Blood Cell Count in Childhood Acute Lymphoblastic Leukemia.Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.The two main forms of histiocytic sarcoma in the predisposed Flatcoated retriever dog display variation in gene expressionVPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Childhood B-acute lymphoblastic leukemia: a genetic update.Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaThe origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution.Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase.Cancer gene prioritization by integrative analysis of mRNA expression and DNA copy number data: a comparative review.The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia.Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL.Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.High-risk pediatric acute lymphoblastic leukemia: to transplant or not to transplant?Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemiaEvaluation of a side population of canine lymphoma cells using Hoechst 33342 dyeUnique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer.Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support.miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.Constitutive function of the Ikaros transcription factor in primary leukemia cells from pediatric newly diagnosed high-risk and relapsed B-precursor ALL patients.Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia.Remaining challenges in childhood cancer and newer targeted therapeutics.
P2860
Q26749177-4E0559E7-B264-4BF6-938D-DD56A57D8131Q26770327-4A86BA87-7706-4E0D-BF40-F67E551843AEQ26770729-821D9796-39E9-4BDA-8EA7-DB0D3C229804Q26824387-CF6A7FAA-AEC1-4888-AE90-445AAC510837Q26864460-49D7CA4A-EBB4-4D29-807F-096ADDDA9D6DQ27853385-FF6E068C-AF3F-484D-9853-3B978B590075Q28080463-65813AE5-9F93-479B-8EEB-8E6F69EF2FCAQ28087446-CCA8A664-AFF5-48CB-B61C-BCC75BBAF9A3Q28274115-5891B0C6-9EC3-4E28-B91E-4DAB7B5644F0Q28306608-1F6F499F-1AB2-4B5C-86E6-AF6F1D3C4E9AQ28390558-1B9521A7-BB8D-4A32-B33A-80FBB4F5A13CQ28602517-3804F2D9-6D1A-4985-B031-15A5162F45A4Q30842603-5D1CFF38-C5FE-4468-B53B-6FE8833300C8Q32182056-731795F9-3416-45B4-A542-1EC7CBE78E13Q33551348-AAD9AC08-36C9-483B-8438-FB08070D0CA1Q33580638-A651AF89-0D56-41E7-9A86-4EABBD81EACFQ33688248-3AE7F8A9-D0B4-403C-9217-948F382118F6Q33700016-16BC17C4-E25B-480C-85E1-94325DBA418CQ33705933-C46904B1-ABD0-4C68-8442-0A7DBF96EED5Q33711119-B390EFAD-0E6B-4084-833E-F01BD6239A80Q33777616-76F24317-EEAB-48AF-BD8C-D436265D36EAQ33998291-3ACC77C6-C37D-4EF3-9FB6-792399309137Q34033206-B1A0A80F-5C22-4BDD-A758-3B71FAC2F822Q34167952-AA75C49F-95FA-4D6A-822E-F8F2BBC2D301Q34172033-95B7A4D7-24D6-4C9B-B05C-80987F8D74D8Q34182738-CCD38CB4-F17B-4496-805F-7B0D3A296B52Q34207183-2CA1CFB4-2C91-43A3-A7BB-A566BB62469AQ34235906-9D7A3644-CF4F-44C5-B693-3423BAE49F00Q34273750-80E6C888-6E33-44DC-9EFA-5BA16EA18D31Q34325528-41D8FB0C-5504-47A4-B4A5-5DDE357D08E3Q34381851-46A81805-36CA-428F-8ADE-7E4C9B8CA96CQ34645259-075942D3-8AD9-42E6-B757-2FEA53423495Q34755687-54C12CC8-235A-4158-8311-7CA58A4A8B2EQ34790870-81244578-C70A-4DE1-AEE7-5C9C83C1D34AQ34820332-D56F5FE3-1102-4AD5-8D6B-07C88A44D065Q34957024-D4679136-7291-4752-982B-861066E8E68EQ35009302-E830DF8A-5C04-43BC-AA3A-A14AC64AF0C1Q35053686-CB9F81EB-0B3A-445E-A082-7068434C30FFQ35079398-75385D2E-5CD5-468F-8B61-3727EC5CAF65Q35106844-C8B6A3B2-E4F4-49AE-B1A1-02C6E2C73051
P2860
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Identification of novel cluste ...... l characteristics, and outcome
@ast
Identification of novel cluste ...... l characteristics, and outcome
@en
type
label
Identification of novel cluste ...... l characteristics, and outcome
@ast
Identification of novel cluste ...... l characteristics, and outcome
@en
prefLabel
Identification of novel cluste ...... l characteristics, and outcome
@ast
Identification of novel cluste ...... l characteristics, and outcome
@en
P2093
P2860
P50
P1433
P1476
Identification of novel cluste ...... l characteristics, and outcome
@en
P2093
Andrew J Carroll
Bruce Camitta
Carla S Wilson
Cheryl L Willman
Edward J Bedrick
George S Davidson
Gregory H Reaman
Huining Kang
I-Ming Chen
James R Downing
P2860
P304
P356
10.1182/BLOOD-2009-08-239681
P407
P577
2010-08-10T00:00:00Z